These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 21831455

  • 1. Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles.
    Klier J, May A, Fuchs S, Schillinger U, Plank C, Winter G, Gehlen H, Coester C.
    Vet Immunol Immunopathol; 2011 Nov 15; 144(1-2):79-87. PubMed ID: 21831455
    [Abstract] [Full Text] [Related]

  • 2. Temporal regulation of cytokine mRNA expression in equine recurrent airway obstruction.
    Horohov DW, Beadle RE, Mouch S, Pourciau SS.
    Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):237-45. PubMed ID: 16098607
    [Abstract] [Full Text] [Related]

  • 3. Cytokine profiles of peripheral blood and airway CD4 and CD8 T lymphocytes in horses with recurrent airway obstruction.
    Kleiber C, McGorum BC, Horohov DW, Pirie RS, Zurbriggen A, Straub R.
    Vet Immunol Immunopathol; 2005 Mar 10; 104(1-2):91-7. PubMed ID: 15661334
    [Abstract] [Full Text] [Related]

  • 4. Increased mucus accumulation in horses chronically affected with recurrent airway obstruction is not associated with up-regulation of CLCA1, EGFR, MUC5AC, Bcl-2, IL-13 and INF-gamma expression.
    Ryhner T, Müller N, Balmer V, Gerber V.
    Vet Immunol Immunopathol; 2008 Sep 15; 125(1-2):8-17. PubMed ID: 18597857
    [Abstract] [Full Text] [Related]

  • 5. Partial divergence of cytokine mRNA expression in bronchial tissues compared to bronchoalveolar lavage cells in horses with recurrent airway obstruction.
    Riihimäki M, Raine A, Art T, Lekeux P, Couëtil L, Pringle J.
    Vet Immunol Immunopathol; 2008 Apr 15; 122(3-4):256-64. PubMed ID: 18243337
    [Abstract] [Full Text] [Related]

  • 6. Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction.
    Ainsworth DM, Wagner B, Franchini M, Grünig G, Erb HN, Tan JY.
    Am J Vet Res; 2006 Apr 15; 67(4):669-77. PubMed ID: 16579761
    [Abstract] [Full Text] [Related]

  • 7. A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses.
    Klier J, Fuchs S, May A, Schillinger U, Plank C, Winter G, Coester C, Gehlen H.
    Pharm Res; 2012 Jun 15; 29(6):1650-7. PubMed ID: 22302522
    [Abstract] [Full Text] [Related]

  • 8. Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma.
    Reinero CR, Cohn LA, Delgado C, Spinka CM, Schooley EK, DeClue AE.
    Vet Immunol Immunopathol; 2008 Feb 15; 121(3-4):241-50. PubMed ID: 17981343
    [Abstract] [Full Text] [Related]

  • 9. Histamine bronchoprovocation does not affect bronchoalveolar lavage fluid cytology, gene expression and protein concentrations of IL-4, IL-8 and IFN-gamma.
    Perkins GA, Viel L, Wagner B, Hoffman A, Erb HN, Ainsworth DM.
    Vet Immunol Immunopathol; 2008 Dec 15; 126(3-4):230-5. PubMed ID: 18829118
    [Abstract] [Full Text] [Related]

  • 10. Nanoparticulate CpG immunotherapy in RAO-affected horses: phase I and IIa study.
    Klier J, Lehmann B, Fuchs S, Reese S, Hirschmann A, Coester C, Winter G, Gehlen H.
    J Vet Intern Med; 2015 Jan 15; 29(1):286-93. PubMed ID: 25619520
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IgE-bearing cells in bronchoalveolar lavage fluid and allergen-specific IgE levels in sera from RAO-affected horses.
    Künzle F, Gerber V, Van Der Haegen A, Wampfler B, Straub R, Marti E.
    J Vet Med A Physiol Pathol Clin Med; 2007 Feb 15; 54(1):40-7. PubMed ID: 17359454
    [Abstract] [Full Text] [Related]

  • 13. Effect of hay dust extract and cyathostomin antigen stimulation on cytokine expression by PBMC in horses with recurrent airway obstruction.
    Lanz S, Gerber V, Marti E, Rettmer H, Klukowska-Rötzler J, Gottstein B, Matthews JB, Pirie S, Hamza E.
    Vet Immunol Immunopathol; 2013 Oct 01; 155(4):229-37. PubMed ID: 23972861
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of serum cytokine levels in recurrent airway obstruction.
    Niedźwiedź A, Borowicz H, Kubiak K, Nicpoń J, Skrzypczak P, Jaworski Z, Cegielski M, Nicpoń J.
    Pol J Vet Sci; 2016 Dec 01; 19(4):785-791. PubMed ID: 28092612
    [Abstract] [Full Text] [Related]

  • 17. Participation of T regulatory cells in equine recurrent airway obstruction.
    Henríquez C, Perez B, Morales N, Sarmiento J, Carrasco C, Morán G, Folch H.
    Vet Immunol Immunopathol; 2014 Apr 15; 158(3-4):128-34. PubMed ID: 24503328
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of cytokine mRNA expression in bronchoalveolar lavage cells from horses with inflammatory airway disease.
    Hughes KJ, Nicolson L, Da Costa N, Franklin SH, Allen KJ, Dunham SP.
    Vet Immunol Immunopathol; 2011 Mar 15; 140(1-2):82-9. PubMed ID: 21194756
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of variations in bronchoalveolar lavage fluid in horses with recurrent airway obstruction.
    Jean D, Vrins A, Beauchamp G, Lavoie JP.
    Am J Vet Res; 2011 Jun 15; 72(6):838-42. PubMed ID: 21627532
    [Abstract] [Full Text] [Related]

  • 20. Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction.
    Art T, Franck T, Lekeux P, de Moffarts B, Couëtil L, Becker M, Kohnen S, Deby-Dupont G, Serteyn D.
    Can J Vet Res; 2006 Oct 15; 70(4):291-6. PubMed ID: 17042382
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.